Annual Interest Expense
$141.86 M
+$20.64 M+17.02%
December 31, 2024
Summary
- As of February 26, 2025, ALNY annual interest expense is $141.86 million, with the most recent change of +$20.64 million (+17.02%) on December 31, 2024.
- During the last 3 years, ALNY annual interest expense has fallen by -$1.16 million (-0.81%).
- ALNY annual interest expense is now -9.05% below its all-time high of $155.97 million, reached on December 31, 2022.
Performance
ALNY Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Interest Expense
$38.97 M
+$4.59 M+13.37%
December 31, 2024
Summary
- As of February 26, 2025, ALNY quarterly interest expense is $38.97 million, with the most recent change of +$4.59 million (+13.37%) on December 31, 2024.
- Over the past year, ALNY quarterly interest expense has increased by +$7.63 million (+24.36%).
- ALNY quarterly interest expense is now -8.54% below its all-time high of $42.61 million, reached on June 30, 2022.
Performance
ALNY Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Interest Expense
$141.86 M
+$7.63 M+5.69%
December 31, 2024
Summary
- As of February 26, 2025, ALNY TTM interest expense is $141.86 million, with the most recent change of +$7.63 million (+5.69%) on December 31, 2024.
- Over the past year, ALNY TTM interest expense has increased by +$20.64 million (+17.02%).
- ALNY TTM interest expense is now -12.90% below its all-time high of $162.87 million, reached on September 30, 2022.
Performance
ALNY TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
ALNY Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.0% | +24.4% | +17.0% |
| 3 y3 years | -0.8% | +24.4% | +17.0% |
| 5 y5 years | +100.0% | +24.4% | +17.0% |
ALNY Interest Expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -9.1% | +17.0% | -8.5% | +34.6% | -12.9% | +18.4% |
| 5 y | 5-year | -9.1% | -100.0% | -8.5% | -100.0% | -12.9% | -100.0% |
| alltime | all time | -9.1% | -100.0% | -8.5% | -100.0% | -12.9% | -100.0% |
Alnylam Pharmaceuticals Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $141.86 M(+17.0%) | $38.97 M(+13.4%) | $141.86 M(+5.7%) |
| Sep 2024 | - | $34.38 M(+3.4%) | $134.22 M(+2.7%) |
| Jun 2024 | - | $33.26 M(-5.7%) | $130.74 M(+2.5%) |
| Mar 2024 | - | $35.25 M(+12.5%) | $127.52 M(+5.2%) |
| Dec 2023 | $121.22 M(-22.3%) | $31.34 M(+1.4%) | $121.22 M(+1.2%) |
| Sep 2023 | - | $30.89 M(+2.9%) | $119.80 M(-7.8%) |
| Jun 2023 | - | $30.04 M(+3.7%) | $129.99 M(-8.8%) |
| Mar 2023 | - | $28.95 M(-3.2%) | $142.56 M(-8.6%) |
| Dec 2022 | $155.97 M(+9.1%) | $29.91 M(-27.2%) | $155.97 M(-4.2%) |
| Sep 2022 | - | $41.08 M(-3.6%) | $162.87 M(+0.5%) |
| Jun 2022 | - | $42.61 M(+0.6%) | $162.06 M(+6.0%) |
| Mar 2022 | - | $42.36 M(+15.1%) | $152.87 M(+6.9%) |
| Dec 2021 | $143.02 M | $36.82 M(-8.6%) | $143.02 M(+6.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $40.27 M(+20.5%) | $134.72 M(+9.4%) |
| Jun 2021 | - | $33.42 M(+2.8%) | $123.18 M(+5.3%) |
| Mar 2021 | - | $32.52 M(+14.0%) | $117.01 M(+38.5%) |
| Dec 2020 | $84.50 M(>+9900.0%) | $28.52 M(-0.7%) | $84.50 M(+50.9%) |
| Sep 2020 | - | $28.73 M(+5.4%) | $55.98 M(+105.4%) |
| Jun 2020 | - | $27.25 M(>+9900.0%) | $27.25 M(>+9900.0%) |
| Mar 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2019 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2019 | - | $0.00 | $0.00 |
| Dec 2018 | $0.00(0.0%) | - | - |
| Dec 2009 | $0.00(-100.0%) | - | - |
| Dec 2008 | $872.00 K(-19.5%) | - | - |
| Dec 2007 | $1.08 M | - | - |
FAQ
- What is Alnylam Pharmaceuticals annual interest expense?
- What is the all time high annual interest expense for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals annual interest expense year-on-year change?
- What is Alnylam Pharmaceuticals quarterly interest expense?
- What is the all time high quarterly interest expense for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals quarterly interest expense year-on-year change?
- What is Alnylam Pharmaceuticals TTM interest expense?
- What is the all time high TTM interest expense for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals TTM interest expense year-on-year change?
What is Alnylam Pharmaceuticals annual interest expense?
The current annual interest expense of ALNY is $141.86 M
What is the all time high annual interest expense for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high annual interest expense is $155.97 M
What is Alnylam Pharmaceuticals annual interest expense year-on-year change?
Over the past year, ALNY annual interest expense has changed by +$20.64 M (+17.02%)
What is Alnylam Pharmaceuticals quarterly interest expense?
The current quarterly interest expense of ALNY is $38.97 M
What is the all time high quarterly interest expense for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high quarterly interest expense is $42.61 M
What is Alnylam Pharmaceuticals quarterly interest expense year-on-year change?
Over the past year, ALNY quarterly interest expense has changed by +$7.63 M (+24.36%)
What is Alnylam Pharmaceuticals TTM interest expense?
The current TTM interest expense of ALNY is $141.86 M
What is the all time high TTM interest expense for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high TTM interest expense is $162.87 M
What is Alnylam Pharmaceuticals TTM interest expense year-on-year change?
Over the past year, ALNY TTM interest expense has changed by +$20.64 M (+17.02%)